Earnings Call · Q3 FY2021·2021-11-02

Q3 21EPS +15.66%·Rev n/aQ2 21EPS +5.41%·Rev n/aQ1 21EPS -100.00%*·Rev n/aQ4 20EPS 0.00%·Rev n/a⚠ consensus missing

RHYTHM PHARMACEUTICALS, INC. RYTM

David Connolly — Head of IR and Corporate Communications

David Meeker — Chief Executive Officer

Linda Shapiro — Senior Executive (likely Head of Clinical Development or similar)

Jennifer Chien — Senior Executive (likely Head of Commercial or similar)

Hunter Smith — Chief Financial Officer

+6.6%1d on move date+6.2% vs SPY3d+11.7%5d+10.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RYTM calls or request research access.

More RYTM calls Browse calls Request research access